Cargando…

Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma

OBJECTIVE: Natural extracts, including nobiletin, have been reported to enhance the efficacy and sensitivity of chemotherapeutic drugs. However, whether and how nobiletin affects tumor growth and progression in renal cell carcinoma (RCC) are still unclear. METHODS: Cell proliferation, cell cycle and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Tingting, Liu, Liu, Zou, Yonghong, Hu, Xiaoyan, Zhang, Wenfeng, Zhou, Tao, Luo, Xi, Fu, Weihua, Xu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877181/ https://www.ncbi.nlm.nih.gov/pubmed/33628597 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0186

Ejemplares similares

MYC Modulation around the CDK2/p27/SKP2 Axis
por: Hydbring, Per, et al.
Publicado: (2017)

Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1
por: Rowland, Rhianna J., et al.
Publicado: (2023)

The Amelioration of Renal Damage in Skp2-Deficient Mice Canceled by p27 (Kip1) Deficiency in Skp2(−/−) p27(−/−) Mice
por: Suzuki, Sayuri, et al.
Publicado: (2012)

Palbociclib-mediated cell cycle arrest can occur in the absence of the CDK inhibitors p21 and p27
por: Pennycook, Betheney R., et al.
Publicado: (2021)

Roles of the Skp2/p27 axis in the progression of chronic nephropathy
por: Suzuki, Sayuri, et al.
Publicado: (2012)

Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer
por: Jung, DeokBeom, et al.
Publicado: (2018)

Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation
por: Salamina, Marco, et al.
Publicado: (2021)

CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradation
por: Xiao, Yingzi, et al.
Publicado: (2023)

The NUCKS1-SKP2-p21/p27 axis controls S phase entry
por: Hume, Samuel, et al.
Publicado: (2021)

1,25-(OH)(2)D(3)/Vitamin D receptor alleviates systemic lupus erythematosus by downregulating Skp2 and upregulating p27
por: Liu, Dan, et al.
Publicado: (2019)

NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis
por: Shen, Liangliang, et al.
Publicado: (2018)

Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 Downregulation
por: Borriello, Adriana, et al.
Publicado: (2016)

Skp2 and Skp2B team up against Rb and p53
por: Germain, Doris
Publicado: (2011)

PI3K regulation of the SKP-2/p27 axis through mTORC2
por: Shanmugasundaram, Karthigayan, et al.
Publicado: (2012)

Mechanism of p27 Unfolding for CDK2 Reactivation
por: Rath, Soumya Lipsa, et al.
Publicado: (2016)

Downregulation of decidual SKP2 is associated with human recurrent miscarriage
por: Lv, Shijian, et al.
Publicado: (2021)

The p27–Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells
por: Kullmann, Michael K, et al.
Publicado: (2013)

SKP2 targeted inhibition suppresses human uveal melanoma progression by blocking ubiquitylation of p27
por: Zhao, Hongbo, et al.
Publicado: (2019)

The SKP2‐p27 axis defines susceptibility to cell death upon CHK1 inhibition
por: Lohmüller, Michael, et al.
Publicado: (2022)

Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality
por: Li, Pu, et al.
Publicado: (2022)

Radiotherapy inhibits neointimal hyperplasia after artificial vascular replacement through Skp2/P27kip1
por: Qiu, Jian, et al.
Publicado: (2021)

P16 methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib
por: Li, Paiyun, et al.
Publicado: (2019)

Associations and prognostic significance of p27(Kip1), Jab1 and Skp2 in non-Hodgkin lymphoma
por: Ma, Yan, et al.
Publicado: (2016)

The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells
por: Lu, Lifang, et al.
Publicado: (2002)

ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis
por: Galeano, F, et al.
Publicado: (2013)

MESP2 binds competitively to TCF4 to suppress gastric cancer progression by regulating the SKP2/p27 axis
por: Ge, Lingjun, et al.
Publicado: (2023)

ZNF292 suppresses proliferation of ESCC cells through ZNF292/SKP2/P27 signaling axis
por: Gong, Wei, et al.
Publicado: (2021)

Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence
por: Pandey, Kamal, et al.
Publicado: (2020)

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells
por: Liu, Yanling, et al.
Publicado: (2020)

Prognostic implication of p27(Kip1), Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study
por: Liu, Zheng, et al.
Publicado: (2008)

Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells via SKP2/P27 signaling pathway
por: Xu, Tianhua, et al.
Publicado: (2017)

Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity
por: Pogacar, Ziva, et al.
Publicado: (2022)

Notch1 modulates timing of G(1)-S progression by inducing SKP2 transcription and p27(Kip1) degradation
por: Sarmento, Leonor M., et al.
Publicado: (2005)

Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy
por: van Aken, Evert S. M., et al.
Publicado: (2021)

SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation
por: Li, Ziming, et al.
Publicado: (2016)

p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer
por: Rampioni Vinciguerra, Gian Luca, et al.
Publicado: (2021)

Tanshinone IIA Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation via Akt/Skp2/p27-Associated Pathway
por: Luo, Ying, et al.
Publicado: (2013)

Novel therapeutic strategy for melanoma based on albendazole and the CDK4/6 inhibitor palbociclib
por: Zhu, Lin, et al.
Publicado: (2022)

Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
por: Guillaume, Zoé, et al.
Publicado: (2020)

USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates
por: Zhang, Fengwu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fcs57qgb2qji9ds1tae38v7s5q